What is TTRX's debt-to-assets?

TTRX (TTRX) reported debt-to-assets of 0.3× in Q1 2026.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

TTRX TTRX Debt-to-assets

Debt-to-assets at other companies

Regeneron PharmaceuticalsREGN

0.1×0.0×

Bausch Health CompaniesBHC

0.8×0.0×

Journey Medical CorporationDERM

0.3×0.0×

PTH

Pelthos Therapeutics Inc.PTHS

0.2×—

Celldex TherapeuticsCLDX

0×0.0×

Arcutis Biotherapeutics, Inc.ARQT

0.2×-0.1×

Other financials

Income statement

See full

Operating income-$1.2M-224%

Net income-$971.0K-196%

EPS (diluted)-$0.03-200%

Balance sheet

See full

Cash & equivalents$11.2M+613%

Total debt$6.0M—

Total equity$6.1M+647%

Total assets$18.6M—

Cash flow

See full

Operating cash flow-$1.6M-448%

Valuation

See full

Market cap$217.45M-17.7%

Enterprise value$212.24M—

Returns & leverage

See full

Return on equity-118.8%—

Debt / equity1×—

Current ratio2.2×—

Where this comes from

Calculated from TTRX’s reported figures.

total debt/total assets=0.3×

Based on the most recent quarter.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TTRX's debt-to-assets?: TTRX (TTRX) reported debt-to-assets of 0.3× in Q1 2026.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.